This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: While big funds play nice, smaller proxy fights show activism still a rough sport

By Jason Booth ( May 2, 2019, 19:53 GMT | Comment) -- While some big funds are rebranding themselves as quiet activists, more interested in constructive discussion with management than turning over tables, three smaller proxy fights this week showed that shareholder activism is still a rough sport, with accusations of off undisclosed penthouses, misuse of corporate jets and questionable oil deals. As the 2019 proxy season approaches its climax, expect the insults to get louder.While some big funds are rebranding themselves as quiet activists, more interested in constructive discussion with management than in turning over tables, three smaller proxy fights this week showed that shareholder activism is still a rough sport, with accusations of undisclosed penthouses, misuse of corporate jets and questionable oil deals. As the 2019 proxy season approaches its climax, expect the insults to get louder....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login